phenanthrene-9,10-dicarboximide | 2510-61-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 菲及其衍生物
• 英文名称: phenanthrene-9,10-dicarboximide
• 英文别名: 1H-dibenzo[e,g]isoindole-1,3(2H)-dione；phenanthro[9,10-c]pyrrole-1,3-dione
• CAS: 2510-61-4
• 化学式: C₁₆H₉NO₂
• 分子量: 247.253
• InChiKey: LCCQEESYPUHVCT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  19
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  3,4-二苯基吡咯-2,5-二酮 以 氘代氯仿 为溶剂， 生成 phenanthrene-9,10-dicarboximide
  参考文献：
  名称：

  烷基马来酰亚胺的合成和光化学反应

  摘要：

  由马来酰亚胺银与烷基溴反应制备的 O-烷基马来酰亚胺的辐照导致 Norrish II 型消除，推测是由激发的碳 - 氮双键的 γ-氢提取引发的。

  DOI：

  10.1246/cl.1981.1473

文献信息

• [EN] NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS<br/>[FR] DÉRIVÉS INÉDITS DE 1,2,3-TRIAZOLE UTILISABLES EN TANT QUE MODULATEURS DES RÉCEPTEURS NICOTINIQUES DE L'ACÉTYLCHOLINE
  申请人：NEUROSEARCH AS

  公开号：WO2009019278A1

  公开（公告）日：2009-02-12

  This invention relates to novel 1,2,3-triazole derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

  这项发明涉及新型的1,2,3-三唑衍生物，发现它们是尼古丁型乙酰胆碱受体的调节剂。由于它们的药理特性，本发明的化合物可能对治疗与中枢神经系统（CNS）的胆碱能系统、外周神经系统（PNS）、平滑肌收缩、内分泌疾病、神经退行性疾病、炎症、疼痛以及由滥用化学物质终止引起的戒断症状等疾病或障碍具有用处。
• Two-Step Synthesis of π-Expanded Maleimides from 3,4-Diphenylfuran-2(5<i>H</i>)-ones
  作者：Yang Kang、Wei Zhang、Tao Wang、Yong Liang、Zunting Zhang

  DOI：10.1021/acs.joc.9b01792

  日期：2019.10.4

  An efficient two-step synthesis of π-expanded maleimide derivatives was reported, which proceeded via a photoinduced dehydrogenative annulation of 3,4-diphenylfuran-2(5H)-ones in EtOH at room temperature for 5 h under an argon atmosphere, followed by interaction with primary amine in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene and O2. The synthesis of highly conjugated maleimides demonstrated

  报道了一种有效的两步合成π扩展的马来酰亚胺衍生物的方法，该方法是通过在室温，氩气气氛下于EtOH中3,4-二苯基呋喃-2（5H）-ones的光诱导脱氢环化反应进行的，历时5 h。 1,8-二氮杂双环[5.4.0]十一碳-7-烯和O2存在下与伯胺的相互作用。高度共轭的马来酰亚胺的合成表明3,4-二苯基呋喃-2（5H）-ones是合成π膨胀内酯和π膨胀马来酰亚胺的有用前体，不需要过渡金属催化剂。另外，表征了高度共轭的马来酰亚胺的荧光性质，并发现其在二氯甲烷溶液中具有高的荧光量子产率。
• Synthesis of dibenzo[e,g]isoindol-1-ones via photoinduced intramolecular annulation of 3,4-diphenyl-1H-pyrrol-2(5H)-ones
  作者：Yang Kang、Yun He、Jingzhi Sui、Tao Wang、Yong Liang、Zunting Zhang

  DOI：10.1016/j.tet.2021.131981

  日期：2021.3

  An efficient, oxidant and photocatalyst-free approach for the synthesis of polycyclic-fused isoindolinone derivatives is reported via annulation of 3,4-diphenyl-3-pyrrolin-2-ones along with release of the hydrogen gas under an argon atmosphere in EtOH by irradiation with a 500 W mercury lamp at room temperature. The described approach is atom-economic and environmentally friendly and tolerates various

  通过3,4-二苯基-3-吡咯啉-2-酮的环化反应，以及在氩气中在氩气氛下通过氢气释放氢气，报道了一种高效，无氧化剂，无光催化剂的合成多环稠合异吲哚啉酮衍生物的方法。在室温下用500 W汞灯照射。所描述的方法是原子经济的和环境友好的，并且可以耐受各种给电子和吸电子基团。另外，在CH 3 ONa存在下，于DMSO中，将选定的环化产物二苯并[ e，g ]异吲哚-1-酮成功氧化为二苯并[ e，g ]异吲哚-1,3（2 H）-二酮。室内温度。
• NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
  申请人：Nardi Antonio

  公开号：US20100222398A1

  公开（公告）日：2010-09-02

  This invention relates to novel 1,2,3-triazole derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

  本发明涉及新颖的1,2,3-三唑衍生物，这些衍生物被发现是乙酰胆碱受体的调节剂。由于它们的药理特性，本发明的化合物可能对治疗与中枢神经系统（CNS）和外周神经系统（PNS）的胆碱能系统相关的疾病或障碍、平滑肌收缩相关的疾病或障碍、内分泌疾病或障碍、神经退行性疾病或障碍、炎症相关的疾病或障碍、疼痛和化学物质滥用终止引起的戒断症状等疾病或障碍有用。
• CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS
  申请人：Klinge Pharma GmbH

  公开号：EP1042315B1

  公开（公告）日：2004-04-14